Address
Email address
Phone number
Website
Roche töötab välja innovaatilisi ravimeid ja diagnostikavahendeid, mis aitavad miljoneid patsiente terves maailmas
Name
Roche Eesti Osaühing
Registry code
11124024
VAT number
EE100987243
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
15.04.2005 (19)
Financial year
01.01-31.12
Capital
127 823.00 €
Activity
74901 - Other professional, scientific and technical activities n.e.c. 46761 - Wholesale of other intermediate products
37 435 000 €
1 012 000 €
3%
6 506 €
(estimate is approximate)
9 820 000 €
28
Submitted
No tax arrears
10%
5%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Kadri Mägi-Lehtsi 23.11.1963 (60) | - | Procurator | Other control or influence (contractual, family or other relationships) | |
Kea Kapsta 26.01.1972 (52) | - | Procurator | Other control or influence (contractual, family or other relationships) | |
Kätlin Luik 10.05.1976 (48) | - | Procurator | Other control or influence (contractual, family or other relationships) | |
Mart Vain 04.03.1986 (38) | - | Procurator | Other control or influence (contractual, family or other relationships) | |
Martin-Kaspar Sild 10.05.1989 (35) | - | Procurator | Other control or influence (contractual, family or other relationships) | |
Stan Nahkor 02.08.1978 (46) | - | Procurator | Other control or influence (contractual, family or other relationships) |
2019 07.08.2020 | 2020 07.05.2021 | 2021 27.06.2022 | 2022 26.06.2023 | 2023 11.06.2024 | |
---|---|---|---|---|---|
Total Revenue | 25 743 000 € | 29 521 000 € | 31 074 000 € | 37 547 000 € | 37 435 000 € |
Net profit (loss) for the period | 667 000 € | 819 000 € | 1 031 000 € | 1 178 000 € | 1 012 000 € |
Profit Margin | 3% | 3% | 3% | 3% | 3% |
Current Assets | 15 270 000 € | 17 110 000 € | 18 327 000 € | 18 602 000 € | 21 467 000 € |
Fixed Assets | 611 000 € | 622 000 € | 646 000 € | 666 000 € | 554 000 € |
Total Assets | 15 881 000 € | 17 732 000 € | 18 973 000 € | 19 268 000 € | 22 021 000 € |
Current Liabilities | 9 710 000 € | 10 885 000 € | 11 042 000 € | 10 123 000 € | 11 945 000 € |
Non Current Liabilities | 391 000 € | 248 000 € | 301 000 € | 337 000 € | 256 000 € |
Total Liabilities | 10 101 000 € | 11 133 000 € | 11 343 000 € | 10 460 000 € | 12 201 000 € |
Share Capital | - | - | - | - | - |
Equity | 5 780 000 € | 6 599 000 € | 7 630 000 € | 8 808 000 € | 9 820 000 € |
Employees | 23 | 25 | 27 | 29 | 28 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | 14 368 515.57 € | 710 768.4 € | 262 913.81 € | 40 |
2023 Q4 | 14 820 558.81 € | 622 566.09 € | 222 730.57 € | 42 |
2023 Q3 | 11 967 874.45 € | 596 318.86 € | 298 659.87 € | 39 |
2023 Q2 | 13 600 088.74 € | 917 477.05 € | 546 488.63 € | 41 |
2023 Q1 | 16 733 279.75 € | 664 163.36 € | 243 972.61 € | 46 |
2022 Q4 | 14 216 392.17 € | 511 528.85 € | 246 442.96 € | 49 |
2022 Q3 | 11 618 013.45 € | 573 874.97 € | 266 824.68 € | 57 |
2022 Q2 | 16 503 047.61 € | 884 005.91 € | 484 157.93 € | 57 |
2022 Q1 | 11 692 082.3 € | 594 342.44 € | 227 274.04 € | 57 |
2021 Q4 | 9 318 199.34 € | 489 346.08 € | 212 227.34 € | 59 |
2021 Q3 | 13 027 920.39 € | 463 371.51 € | 252 542.59 € | 60 |
2021 Q2 | 10 739 551 € | 758 353.36 € | 375 587.05 € | 60 |
2021 Q1 | 10 229 222.37 € | 520 910.96 € | 199 058.51 € | 60 |
2020 Q4 | 12 449 889.14 € | 483 769.32 € | 195 035.48 € | 66 |
2020 Q3 | 8 285 768.56 € | 630 823.71 € | 242 931.07 € | 66 |
2020 Q2 | 11 301 347.67 € | 779 322.77 € | 452 861.62 € | 64 |
2020 Q1 | 9 436 989.16 € | 490 764.27 € | 188 776.23 € | 58 |